BrainStorm Granted Patents for Allogeneic Exosome Platform-Product in Neurological Disorder Treatments
NEW YORK, Dec. 26, 2023 /PRNewswire/ -- Brainstorm Cell Therapeutics Inc. , a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today provided an update on the grant...